| [March 05, 2015] |
 |
Research and Markets: Alzheimer's Disease Pipeline Review 2015 - Featuring 200+ Companies
Research and Markets (http://www.researchandmarkets.com/research/6bw4l3/alzheimers)
has announced the addition of the "Alzheimer's
Disease - Pipeline Review, H1 2015" report to their offering.
This report provides comprehensive information on the therapeutic
development for Alzheimer's Disease, complete with comparative analysis
at various stages, therapeutics assessment by drug target, mechanism of
action (MoA), route of administration (RoA) and molecule type, along
with latest updates, and featured news and press releases. It also
reviews key players involved in the therapeutic development for
Alzheimer's Disease and special features on late-stage and discontinued
projects.
The report enhances decision making capabilities and help to create
effective counter strategies to gain competitive advantage. It
strengthens R&D pipelines by identifying new targets and MoAs to produce
first-in-class and best-in-class products.
Key Topics Covered:
-
Introduction
-
Alzheimer's Disease Overview
-
Therapeutics Development
/li>
-
Alzheimer's Disease - Therapeutics under Development by Companies
-
Alzheimer's Disease - Therapeutics under Investigation by
Universities/Institutes
-
Alzheimer's Disease - Pipeline Products Glance
-
Alzheimer's Disease - Products under Development by Companies
-
Alzheimer's Disease - Products under Investigation by
Universities/Institutes
-
Alzheimer's Disease - Companies Involved in Therapeutics Development
-
Alzheimer's Disease - Therapeutics Assessment
-
Drug Profiles
-
Alzheimer's Disease - Recent Pipeline Updates
-
Alzheimer's Disease - Dormant Projects
-
Alzheimer's Disease - Discontinued Products
-
Alzheimer's Disease - Product Development Milestones
-
Appendix
Companies Mentioned
-
AB Science
-
AbbVie Inc.
-
AC Immune SA
-
Acadia Pharmaceuticals Inc.
-
AstraZeneca PLC
-
Ausio Pharmaceuticals, LLC
-
K-Stemcell Co., Ltd.
-
Kadmon Corporation, LLC
-
Kareus Therapeutics, SA
-
KineMed, Inc.
-
Kyowa Hakko Kirin Co., Ltd.
-
Medisyn Technologies, Inc.
-
Merck & Co., Inc.
-
Merz Pharma GmbH & Co. KgaA
-
Metabolic Solutions Development Company, LLC
-
Mezzion Pharma Co. Ltd.
-
Mithridion, Inc.
-
NAL Pharmaceuticals Ltd.
-
ReGenX Biosciences, LLC
-
reMYND
-
Resverlogix Corp.
-
Reviva Pharmaceuticals Inc.
-
Sage Therapeutics
-
Saneron CCEL Therapeutics, Inc.
-
Sangamo BioSciences, Inc.
-
Sanofi
-
Selvita SA
-
Serometrix, LLC
-
Suven Life Sciences Ltd.
-
Takeda Pharmaceutical Company Limited
For more information visit http://www.researchandmarkets.com/research/6bw4l3/alzheimers
About Research and Markets
Research and Markets is the world's leading source for international
market research reports and market data. We provide you with the latest
data on international and regional markets, key industries, the top
companies, new products and the latest trends.
[ Back To TMCnet.com's Homepage ]
|
